STOCK TITAN
  1. Home
  2. Sec-filings
  3. IRIX
  4. [Form 4] IRIDEX CORP Insider Trading Activity

IRIDEX (IRIX) director William Moore reports 20,000-share stock purchase

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IRIDEX director William M. Moore reported buying 20,000 shares of IRIDEX common stock on 12/15/2025, shown as a purchase transaction.

The shares were acquired in multiple trades at weighted average prices between $0.98 and $0.9885 per share. Following this transaction, Moore directly owned 249,550 IRIDEX shares, with an additional 69,300 shares held indirectly by his spouse and 81,150 shares held indirectly through the William M. Moore Trust and the Patricia A. Moore Trust as tenants in common.

Positive

  • None.

Negative

  • None.
Insider MOORE WILLIAM M
Role Director
Bought 20,000 shs ($0.00)
Type Security Shares Price Value
Purchase Common Stock 20,000 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 249,550 shares (Direct); Common Stock — 69,300 shares (Indirect, By Spouse)
Footnotes (1)
  1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.98 to $0.9885, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MOORE WILLIAM M
(Last) (First) (Middle)
1212 TERRA BELLA AVENUE
(Street)
MOUNTAIN VIEW CA 94043
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
IRIDEX CORP [ IRIX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/15/2025 P 20,000 A (1) 249,550 D
Common Stock 69,300 I By Spouse
Common Stock 81,150 I See Footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.98 to $0.9885, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
2. The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.
/s/ Nilo De Castro, Attorney-in-fact for William M. Moore 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did IRIDEX (IRIX) director William M. Moore report?

William M. Moore reported purchasing 20,000 shares of IRIDEX common stock on 12/15/2025, coded as a purchase in the Form 4.

At what prices were the IRIDEX (IRIX) shares bought in this Form 4 filing?

The filing states that the 20,000 shares were purchased in multiple transactions at prices ranging from $0.98 to $0.9885 per share, on a weighted average basis.

How many IRIDEX (IRIX) shares does William M. Moore own after this transaction?

After the reported purchase, William M. Moore directly owned 249,550 IRIDEX shares, with 69,300 shares held indirectly by his spouse and 81,150 shares held indirectly through family trusts.

What is William M. Moore’s relationship to IRIDEX (IRIX)?

The Form 4 identifies William M. Moore as a Director of IRIDEX Corporation.

How are some of William M. Moore’s IRIDEX (IRIX) shares held indirectly?

The filing explains that 81,150 shares are held by the William M. Moore Trust and the Patricia A. Moore Trust, as tenants in common.